228 related articles for article (PubMed ID: 3555052)
1. Oral ciprofloxacin in resistant urinary tract infections.
Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
[TBL] [Abstract][Full Text] [Related]
2. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
3. Use of intravenous ciprofloxacin in difficult-to-treat infections.
Giamarellou H; Galanakis N
Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin: an update on clinical experience.
Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
[TBL] [Abstract][Full Text] [Related]
8. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
Harding GK; Ronald AR; Boutros P; Lank B
Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
[TBL] [Abstract][Full Text] [Related]
9. Norfloxacin versus co-trimoxazole for the treatment of upper urinary tract infections: a double blind trial.
Tungsanga K; Chongthaleong A; Udomsantisuk N; Petcharabutr OA; Sitprija V; Wong EC
Scand J Infect Dis Suppl; 1988; 56():28-34. PubMed ID: 3074463
[TBL] [Abstract][Full Text] [Related]
10. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
Fass RJ
Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
[TBL] [Abstract][Full Text] [Related]
12. Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Lesse AJ; Freer C; Salata RA; Francis JB; Scheld WM
Am J Med; 1987 Apr; 82(4A):247-53. PubMed ID: 3555043
[TBL] [Abstract][Full Text] [Related]
13. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
14. Treatment of lower urinary tract infections with single-dose trimethoprim-sulfamethoxazole.
Prentice RD; Wu LR; Gehlbach SH; Hanlon JT; Clapp-Channing NE; Finn AL
J Fam Pract; 1985 Jun; 20(6):551-7. PubMed ID: 3873511
[TBL] [Abstract][Full Text] [Related]
15. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
Scully BE; Jules K; Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
[TBL] [Abstract][Full Text] [Related]
16. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects.
Naber KG; Bauernfeind A; Dietlein G; Wittenberger R
Scand J Urol Nephrol Suppl; 1987; 104():47-57. PubMed ID: 3501901
[TBL] [Abstract][Full Text] [Related]
17. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
Stein GE; Mummaw N; Goldstein EJ; Boyko EJ; Reller LB; Kurtz TO; Miller K; Cox CE
Arch Intern Med; 1987 Oct; 147(10):1760-2. PubMed ID: 3310941
[TBL] [Abstract][Full Text] [Related]
18. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
[TBL] [Abstract][Full Text] [Related]
19. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
Lorian V; Pavletich K
Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.
Saavedra S; Ramírez-Ronda CH; Nevárez M
Eur J Clin Microbiol; 1986 Apr; 5(2):255-7. PubMed ID: 2941296
[No Abstract] [Full Text] [Related]
[Next] [New Search]